Follicular lymphoma grade IIIa
ICD-10 C82.3 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia.
Follicular lymphoma grade IIIa is a subtype of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is classified as a low-grade lymphoma but can exhibit aggressive behavior, particularly in its grade IIIa form, where there is a predominance of large cells. This condition typically presents with painless lymphadenopathy, and patients may experience systemic B-symptoms such as fever, night sweats, and weight loss. Diagnosis is confirmed through histological examination of lymph node biopsies, which reveal a mixture of small and large cells. Staging is crucial for treatment planning and is typically performed using the Ann Arbor system, which assesses the extent of lymph node involvement and any extranodal disease. Treatment options may include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, or a combination of these modalities, depending on the stage and symptoms. The prognosis varies, with factors such as age, performance status, and response to initial therapy playing significant roles in outcomes.
Detailed pathology reports, treatment plans, and follow-up notes are essential.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing chemotherapy.
Accurate grading and staging are critical for treatment decisions and prognosis.
Comprehensive biopsy reports detailing cell types and grades.
Biopsy evaluations of lymph nodes suspected of lymphoma.
Clear differentiation between lymphoma grades is vital for accurate coding.
Used during treatment of follicular lymphoma grade IIIa.
Document the specific chemotherapy agents used and the patient's response.
Oncology specialists must ensure accurate coding of chemotherapy regimens.
Common treatments include chemotherapy, immunotherapy, and in some cases, radiation therapy, depending on the stage and symptoms of the disease.
